Domov › Atopični dermatitis (ekcem) › Ohio
Klinične študije za Atopični dermatitis (ekcem) v Ohio
10 študij za Atopični dermatitis (ekcem) išče udeležence na lokacijah v Ohio.
Mesta v Ohio
Uradno besedilo študije (angleško)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Dermatology Associates of Mid-Ohio- Site Number : 8400026, Marion
- Dermatologists of Southwest Ohio - Mason- Site Number : 8400050, Mason
Vključevanje udeležencevOpazovalna študija
Starost 12 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Canton
- Enveda Investigative Site, Mayfield Heights
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Apex Clinical Research Center, LLC., Mayfield Heights
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Boardman
- Investigational Site, Mason
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07003425A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ClinOhio Research Services, Columbus
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 9, Columbus
- Inmagene Site 5, Mayfield Heights
Vključevanje udeležencevFaza 2
Starost 18–74 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- DOCS Clinical Research - Canal Winchester /ID# 268271, Canal Winchester
- Wright State Physicians Health Center /ID# 268841, Fairborn
Vključevanje udeležencevFaza 3
Starost 2–11 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06461897Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
Vključevanje udeležencevFaza 1
Starost 6 in več · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Apex Clinical Research Center, Mayfield Heights
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 4. maj 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7081, Dayton
Vključevanje udeležencevOpazovalna študija
Starost 12 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT06988605Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.